Clinical trial
Effects of Naltrexone on Nicotine Reinforcement
NCT00270231 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00270231 |
|---|---|
| Title | Effects of Naltrexone on Nicotine Reinforcement |
| Official title | Pharmacogenetic Investigation of Naltrexone |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tobacco Dependence |
| Intervention type | Drug |
| Interventions | Naltrexone, Placebo |
| Enrollment | 64 |
| Start date | Mar 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Dec 26, 2005 |
| Last update posted | Dec 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: